2024 |
Glenmark Pharmaceuticals Ltd.
|
Executive Director & Group CFO |
10.2 Cr |
-0.3 % |
2023 |
Glenmark Pharmaceuticals Ltd.
|
Executive Director & Group CFO |
10.2 Cr |
30.2 % |
2023 |
Alivus Life Sciences Ltd.
|
Non Executive Director |
- |
- |
2022 |
Glenmark Pharmaceuticals Ltd.
|
Executive Director & CFO |
7.9 Cr |
26.5 % |
2022 |
Alivus Life Sciences Ltd.
|
Director |
- |
- |
2021 |
Glenmark Pharmaceuticals Ltd.
|
Executive Director & CFO |
6.2 Cr |
20.9 % |
2020 |
Glenmark Pharmaceuticals Ltd.
|
Whole Time Director & CFO |
5.2 Cr |
12.9 % |
2019 |
Glenmark Pharmaceuticals Ltd.
|
Whole Time Director & CFO |
4.6 Cr |
- |
2018 |
Glenmark Pharmaceuticals Ltd.
|
Whole Time Director & CFO |
- |
- |